New Hope for Long COVID Fatigue: Common Antidepressant Shows Promise in Clinical Trial

A widely available and affordable antidepressant, fluvoxamine, has demonstrated significant potential in alleviating the debilitating fatigue associated with long COVID, offering a glimmer of hope for millions grappling with the persistent aftermath of the virus.

Loading lens…